| Autor: |
Staffurth, John N., Haviland, Joanne S., Wilkins, Anna, Syndikus, Isabel, Khoo, Vincent, Bloomfield, David, Parker, Chris, Logue, John, Scrase, Christopher, Birtle, Alison, Malik, Zafar, Panades, Miguel, Eswar, Chinnamani, Graham, John, Russell, Martin, Ferguson, Catherine, O’Sullivan, Joe M., Cruickshank, Clare A., Dearnaley, David, Hall, Emma |
| Zdroj: |
European Urology Oncology; December 2021, Vol. 4 Issue: 6 p980-992, 13p |
| Abstrakt: |
Moderate hypofractionation is the recommended standard of care for localised prostate cancer following the results of trials including Conventional or Hypofractionated High Dose Intensity Modulated Radiotherapy in Prostate Cancer (CHHiP). Evaluation of long-term patient-reported outcomes (PROs) is important to confirm safety and enhance patient information. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
Full Text from ScienceDirect